2m 2m 2m 2m 2m 2m 2m
AKANDA (AKAN)
NASDAQ
$15.63-$0.55 (-3.40%)
Price as of Jun 23, 2026 7:57 PM EDT- $8.2MMarket Cap
- -80.90%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AKANDA (AKAN)
$15.63-$0.55 (-3.40%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 258,075 -69.15% | 836,664 -61.27% | 2.2M -17.55% | 2.6M +6,223.00% | |
Cost of Revenue | 414,098 -34.09% | 628,282 -67.08% | 1.9M +237.04% | 566,252 +1,216.19% | |
Gross Profit | -156,023 -174.87% | 208,382 +86.98% | 111,449 -96.59% | 3.3M +557.46% | |
Sales and Marketing Expense | 2.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 433,693 +207.47% | 141,054 -96.71% | 4.3M +13.83% | 3.8M +1,117.82% | |
Total Operating Expenses | 2.3M +82.85% | 1.3M +149.55% | 505,187 -85.01% | 3.4M +124.02% | |
Operating Profit | -5.0M +13.71% | -4.4M -56.40% | -10.1M -50.18% | -20.2M +195.25% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -448,417 +14,103.90% | -3,157 -78.43% | -14,638 N/A | N/A N/A | |
Interest Income and Expense and Net | -448,417 +14,103.90% | -3,157 -78.43% | -14,638 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 448,417 +87.97% | 238,553 +3,281.33% | 7,055 +100.54% | -1.3M 0.00% | |
Income before Taxes | -45.7M +1,014.59% | -4.1M -87.31% | -32.3M +176.86% | -11.7M +43.37% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -45.7M +1,014.59% | -4.1M -87.31% | -32.3M +176.86% | -11.7M +43.37% | |
Net Income from Continuing Operations Applicable to Common | -45.7M +1,014.59% | -4.1M -87.31% | -32.3M +176.86% | -11.7M +43.37% | |
Basic EPS and Net Income | -662.22 +16,750.38% | -3.93 -45.11% | -7.16 +1,735.90% | -0.39 -22.00% | |
Diluted EPS and Net Income | -662.22 +16,750.38% | -3.93 -45.11% | -7.16 +1,735.90% | -0.39 -22.00% | |
Basic Weighted Average Shares | 68,941 -93.38% | 1.0M -76.87% | 4.5M -84.95% | 29.9M +84.48% | |
Diluted Weighted Average Shares | 68,941 -93.38% | 1.0M -76.87% | 4.5M -84.95% | 29.9M +84.48% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 503,562 -86.88% | 3.8M +4,535.16% | 82,816 -63.80% | 228,794 -93.45% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 503,562 -86.88% | 3.8M +4,535.16% | 82,816 -63.80% | 228,794 -93.45% | |
Total Current Assets | 3.6M -28.75% | 5.1M +179.95% | 1.8M -52.74% | 3.8M -4.00% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 2.4M +1.14% | 2.3M -7.15% | 2.5M -79.28% | 12.2M +540.73% | |
Total Long-Term Assets | 2.6M -9.27% | 2.9M -59.36% | 7.0M -80.00% | 35.2M +765.18% | |
Total Assets | 6.2M -21.71% | 7.9M -10.47% | 8.8M -77.33% | 39.0M +384.67% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.0M +185.40% | 352,814 -74.18% | 1.4M N/A | N/A N/A | |
Total Current Liabilities | 6.2M +70.43% | 3.6M -64.24% | 10.2M +8.81% | 9.3M +13.05% | |
Total Long-Term Debt | 124,890 0.00% | 124,890 +239.64% | 36,771 N/A | N/A N/A | |
Total Long-Term Liabilities | 12.0M +8,901.47% | 133,163 -94.67% | 2.5M -9.16% | 2.7M +38.90% | |
Total Liabilities | 18.2M +399.95% | 3.6M -71.29% | 12.7M +4.73% | 12.1M +18.05% | |
Retained Earnings | -103.1M +79.42% | -57.5M +7.68% | -53.4M +153.05% | -21.1M +58.63% | |
Total Stockholders Equity | -12.0M -380.38% | 4.3M +211.69% | -3.8M -114.23% | 26.9M +1,321.94% | |
Total Shares Outstanding | 440,775 -78.47% | 2.0M -63.62% | 5.6M -83.75% | 34.6M +55.80% | |
Cash Flow | |||||
Cash from Operating Activities | -6.7M +69.06% | -4.0M +165.26% | -1.5M -86.92% | -11.5M N/A | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -7.5M +633.33% | -1.0M -4,182.95% | 24,888 +100.59% | -4.2M +631.81% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 11.7M +29.91% | 9.0M +504.71% | 1.5M -89.49% | 14.1M +25.84% | |
Financials Ratio | |||||
Gross Margin | -60.46% -342.74% | 24.91% +113.88% | 11.65% -85.14% | 78.38% N/A | |
Operating Margin | -1,930.99% +268.65% | -523.80% +12.57% | -465.33% -39.58% | -770.18% N/A | |
Return on Assets | -647.13% +1,223.49% | -48.90% -63.76% | -134.94% +172.26% | -49.56% N/A | |
Return on Equity | 1,183.68% +164.68% | -1,830.03% +554.08% | -279.79% +196.39% | -94.40% N/A | |
Revenue Growth | -69.15% +12.87% | -61.27% +249.19% | -17.55% -100.28% | 6,223.00% N/A | |
Current Ratio | 0.58 -58.20% | 1.39 +682.99% | 0.18 -56.58% | 0.41 N/A | |
Cash Ratio | 0.08 -92.31% | 1.06 +12,928.40% | 0.008 -66.94% | 0.02 N/A | |
Debt-to-Equity Ratio | -0.09 -184.51% | 0.11 +130.49% | -0.37 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.18 +202.48% | 0.06 -61.94% | 0.16 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow